FDA Reviewer Says 5 Drugs Need Closer Scrutiny
611669
WASHINGTON/NEW YORK  - A U.S. Food and Drug  Administration reviewer who has accused the agency of being lax  in monitoring drug safety on Thursday said five medicines on  the market need closer scrutiny.
386658
The U.S. Food and Drug Administration is facing new questions about its ability to police the safety of medicines after they reach the market following concerns about a widely used diabetes drug.
137276
ROCKVILLE, Md.  - The U.S. Food and Drug  Administration on Friday asked an outside group to review the  way the agency monitors safety risks of medicines after they  hit the market, such as Merck & Co. Inc.'s withdrawn painkiller  Vioxx.
459725
A top Republican lawmaker raised concerns about the U.S. Food and Drug Administration's ability to monitor drug safety following Merck & Co. Inc.'s recall of its arthritis drug last week, according to a letter made public on Tuesday.
270368
Merck &amp; Co.&#39;s recall of the Vioxx painkiller shows why the US Food and Drug Administration needs its safety monitors to be independent of those who approve new medicines, FDA scientist David J. Graham told a Senate hearing.
159888
ROCKVILLE, Md.  - The U.S. Food and Drug  Administration on Friday asked an outside group to review the  way it monitors safety risks associated with medicines already  on the market, such as Merck & Co. Inc.'s withdrawn painkiller  Vioxx.
215621
The U.S. Food and Drug Administration  said on Friday that Senate testimony by a veteran FDA  researcher regarding safety risks for five drugs does not  reflect the views of the agency.
518488
The US regulator to beef up monitoring of drug safety after criticism over a painkiller linked to heart disease.
346497
An FDA review of AstraZeneca Plc&#39;s (AZN.L: Quote, Profile, Research) (AZN.N: Quote, Profile, Research) Exanta questioned the experimental drug&#39;s
121562
Almost one-fifth of the Food and Drug Administration scientists surveyed two years ago as part of an official review said they had been pressured to recommend approval of a new
21984
A drug safety reviewer said the FDA is "incapable of protecting" the public and urged the government to review five new drugs for safety issues.
42599
The U.S. Food and Drug   Administration needs more staff and funding to fix its   monitoring of drug safety after medicines are on the market,   the Institute of Medicine (IOM) said on Friday.
732137
U.S. health officials said on Friday they would review whether to take regulatory action over Merck & Co Inc and Schering-Plough's cholesterol medicine Vytorin following the drug's failure to work better than a generic drug in a study of plaque build-up in neck arteries.
205695
The US Food and Drug Administration on Friday asked an outside group to review the way it monitors safety risks associated with medicines already on the market, such as Merck &amp; Co.
118476
Critics say the F.D.A.'s efforts to monitor the ill effects of drugs that are on the market are a shadow of what they should be.
75126
A senior United States drug official last night said he believed at least another five medicines at present on sale needed further scrutiny in the wake of recent health scares.
35834
The Food and Drug Administration needs more staff, funding and authority over the drug industry to better track the safety of medicines after they reach the market, an Institute of Medicine report said Friday.